Come up with a name for your new list and we'll add to it:
LTS Lohmann Therapie-Systeme raised a round of funding on July 17, 2014. Investors include
dievini Hopp BioTech Holding & Co..
LTS is the global market leader in the development and manufacturing of innovative transdermal systems LTS TTS and oral thin films LTS OTF. Founded in 1984, LTS is a German based pharmaceutical compan…